Learn more

ANTEROGEN CO LTD

Overview
  • Total Patents
    78
  • GoodIP Patent Rank
    46,371
  • Filing trend
    ⇩ 20.0%
About

ANTEROGEN CO LTD has a total of 78 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 2002. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are LINEAGE CELL THERAPEUTICS INC, AAL SCIENT INC and DITESAN LTD.

Patent filings per year

Chart showing ANTEROGEN CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lee Sung-Koo 27
#2 Kim Mi Hyung 20
#3 Croissant Jeffrey D 19
#4 Lee Sung Koo 19
#5 Kim Mi-Hyung 14
#6 Lee Ike W 14
#7 Kim Mihyung 13
#8 Liu Guizhen 9
#9 Hampe James 9
#10 Kim Inok 5

Latest patents

Publication Filing date Title
KR20200112741A injectable composition comprising mesenchymal stem cells-hydrogel and preparation, freeze and thaw method thereof
WO2020190094A1 Injection formulation composition containing mesenchymal stem cell-hydrogel and method for preparing, freezing and defrosting same
KR20200000416A Mesenchymal stem cell culture media for preventing or treating inflammatory disease and a method for preparing the same
KR20200000415A Mesenchymal stem cell culture media for preventing or treating immune disease or inflammatory disease and a method for preparing the same
CN111481572A Autologous and homologous adipose-derived mesenchymal stem cell composition for curing tendon or ligament injury and preparation method thereof
KR20190004253A Mesenchymal stem cell culture media for preventing or treating inflammatory disease and a method for preparing the same
KR20180072644A Mesenchymal stem cell culture media for preventing or treating immune disease or inflammatory disease and a method for preparing the same
WO2018182356A1 Culture containing high concentration of mesenchymal stem cell-derived high-purity exosome, and preparation method therefor
KR20180111674A Media including mesenchymal stem cells derived high purity and high concentration exosome and the producing method thereof
TW201914581A Mesenchymal stem cells-hydrogel-biodegradable or mesenchymal stem cells-hydrogel-nondegradable support composition for alleviating or improving epidermolysis bullosa
KR20160105363A Composition comprising autologous and allogenic adipose tissue-derived stromal stem cells for treatment of tendon or ligament injury and preparation method thereof
KR20170116664A Composition for alleviating or improving epidermolysis bullosa comprising Mesenchymal Stem cells-Hydrogel-Biodegradable scaffold or Mesenchymal Stem cells-Hydrogel-Nondegradable scaffold
KR20170111057A Mesenchymal stem cell culture media for preventing or treating immune disease or inflammatory disease and a method for preparing the same
KR101585032B1 Composition comprising mesenchymal stem cell-hydrogel and preparation method thereof
KR20160034690A Composition comprising mesenchymal stem cell-hydrogel and preparation method thereof
EP3092989A1 Mesenchymal stem cells-hydrogel-biodegradable or mesenchymal stem cells-hydrogel-non-degradable support composition for skin regeneration or wound healing
KR20150138700A Composition comprising autologous and allogenic adipose tissue-derived stromal stem cells for treatment of tendon or ligament injury and preparation method thereof
KR20150029280A Autologous and allogenic adipose tissue-derived mesenchymal stem cells composition for treatment of diabetic wound
KR101297829B1 Detection markers of differentiation potency of adipocyte-derived stem cells and use thereof
CN102421444A Autologous and allogenic adipose-derived stromal stem cell composition for treating fistulas